RADIOPHARM THERANOSTICS LTD RADX
SPONSORED ADS · ADR · CUSIP 75041J101
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $0.09.
Trends to Q4 2025
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2024 | 5 |
| Q1 2025 | 4 |
| Q2 2025 | 6 |
| Q3 2025 | 4 |
| Q4 2025 | 11 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2025 | 0 | 2 |
| Q2 2025 | 2 | 1 |
| Q3 2025 | 2 | 1 |
| Q4 2025 | 7 | 1 |
Biggest buyers
| Stonepine Capital Management, LLC | New | +51.0m |
| HSBC HOLDINGS PLC | New | +383.2k |
| Virtu Financial LLC | New | +14.6k |
| JANE STREET GROUP, LLC | New | +14.5k |
| Marex Group Ltd | New | +10.3k |
| Strategic Wealth Partners, Ltd. | New | +10 |
| RHUMBLINE ADVISERS | New | +6 |
Biggest sellers
| UBS Group AG | Reduced | -3.9k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| Lantheus Holdings, Inc. 13G · passive investor -3.6 pts · filed 2026-09-04 | 17.3% |
| REGAL PARTNERS HOLDINGS PTY LTD 13G · institution +1.8 pts · filed 2026-01-08 | 9.1% |
Fell to 5% or below in the last year: Regal Partners Funds Management Pty Ltd (3.3%, 2026-10-14; now reported by REGAL PARTNERS HOLDINGS PTY LTD), JPMORGAN CHASE & CO (4.0%, 2026-01-16)
Insider purchases and sales in Q4 2025
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q4 2025.
Holders, Q4 2025
| Manager | Shares | Change |
|---|---|---|
| Stonepine Capital Management, LLC 0.67% of their portfolio | 51.0m $850.9k | New |
| HSBC HOLDINGS PLC 0.00% of their portfolio | 383.2k $2.0m | New |
| SILVERARC CAPITAL MANAGEMENT, LLC 0.14% of their portfolio | 187.4k $978.3k | Unchanged |
| Regal Partners Ltd 0.03% of their portfolio | 90.9k $474.5k | Unchanged |
| PNC Financial Services Group, Inc. 0.00% of their portfolio | 16.0k $83.5k | Unchanged |
| Virtu Financial LLC 0.00% of their portfolio | 14.6k $76.0k | New |
| JANE STREET GROUP, LLC 0.00% of their portfolio | 14.5k $75.5k | New |
| UBS Group AG 0.00% of their portfolio | 14.3k $74.5k | Reduced -3.9k |
| Marex Group Ltd 0.00% of their portfolio | 10.3k $53.7k | New |
| Strategic Wealth Partners, Ltd. 0.00% of their portfolio | 10 $52 | New |
| RHUMBLINE ADVISERS 0.00% of their portfolio | 6 $31 | New |